tiprankstipranks
Tsumura & Co. (JP:4540)
:4540
Holding JP:4540?
Track your performance easily

Tsumura & Co (4540) Stock Price & Analysis

1 Followers

4540 Stock Chart & Stats


Options Prices

Currently, No data available
---

Ownership Overview

5.49%89.59%
Insiders
― Other Institutional Investors
89.59% Public Companies and
Individual Investors

4540 FAQ

What was Tsumura & Co.’s price range in the past 12 months?
Tsumura & Co. lowest stock price was ¥2656.00 and its highest was ¥5138.00 in the past 12 months.
    What is Tsumura & Co.’s market cap?
    Tsumura & Co.’s market cap is $342.60B.
      When is Tsumura & Co.’s upcoming earnings report date?
      Tsumura & Co.’s upcoming earnings report date is Feb 06, 2025 which is in 18 days.
        How were Tsumura & Co.’s earnings last quarter?
        Tsumura & Co. released its earnings results on Nov 07, 2024. The company reported ¥83.26 earnings per share for the quarter, missing the consensus estimate of ¥93.54 by -¥10.28.
          Is Tsumura & Co. overvalued?
          According to Wall Street analysts Tsumura & Co.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Tsumura & Co. pay dividends?
            Tsumura & Co. pays a Annually dividend of ¥68 which represents an annual dividend yield of 2.76%. See more information on Tsumura & Co. dividends here
              What is Tsumura & Co.’s EPS estimate?
              Tsumura & Co.’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Tsumura & Co. have?
              Tsumura & Co. has 76,758,360 shares outstanding.
                What happened to Tsumura & Co.’s price movement after its last earnings report?
                Tsumura & Co. reported an EPS of ¥83.26 in its last earnings report, missing expectations of ¥93.54. Following the earnings report the stock price went up 0.813%.
                  Which hedge fund is a major shareholder of Tsumura & Co.?
                  Currently, no hedge funds are holding shares in JP:4540
                  ---

                  Company Description

                  Tsumura & Co.

                  Tsumura & Co is a specialty and generic drug manufacturing company. The company generates most of its revenue through prescription Kampo products, followed by over-the-counter medicines. Tsumura promotes its products through educational support at medical schools and by hosting seminars for physicians and consumers. The company considers strategic collaboration agreements to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
                  ---

                  4540 Stock 12 Month Forecast

                  Average Price Target

                  ¥6,426.27
                  ▲(42.46% Upside)
                  {"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2581":"¥2,581","4504":"¥4,504","6427":"¥6,427","3542.5":"¥3,542.5","5465.5":"¥5,465.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":6426.080320397045,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">¥6K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":6426.2746764,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">¥6K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":6426.080320397045,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">¥6K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[2581,3542.5,4504,5465.5,6427],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Feb<br/>2024","6":"May<br/>2024","9":"Aug<br/>2024","12":"Nov<br/>2024","25":"Nov<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4880,4998.929255415157,5117.858510830315,5236.787766245472,5355.717021660629,5474.646277075786,5593.575532490944,5712.504787906101,5831.434043321258,5950.363298736416,6069.292554151573,6188.22180956673,6307.151064981888,{"y":6426.080320397045,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4880,4998.944205876923,5117.888411753846,5236.832617630769,5355.776823507693,5474.721029384616,5593.665235261538,5712.609441138462,5831.553647015385,5950.4978528923075,6069.442058769231,6188.386264646154,6307.330470523078,{"y":6426.2746764,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4880,4998.929255415157,5117.858510830315,5236.787766245472,5355.717021660629,5474.646277075786,5593.575532490944,5712.504787906101,5831.434043321258,5950.363298736416,6069.292554151573,6188.22180956673,6307.151064981888,{"y":6426.080320397045,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":2619.54,"date":1698796800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":2703.634,"date":1701388800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":2582.598,"date":1704067200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":2620.513,"date":1706745600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":2684.677,"date":1709251200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3776.333,"date":1711929600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3728.07,"date":1714521600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3890.588,"date":1717200000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":4064.926,"date":1719792000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3769.438,"date":1722470400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3883.693,"date":1725148800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3883.693,"date":1725148800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":4880,"date":1730419200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Chugai Pharmaceutical Co
                  Sumitomo Dainippon Pharma Co
                  Shionogi & Co
                  Takeda Pharmaceutical Co
                  Astellas Pharma

                  Best Analysts Covering 4540

                  1 Year
                  1 Year Success Rate
                  1/2 ratings generated profit
                  50%
                  1 Year Average Return
                  -3.10%
                  reiterated a buy rating 2 months ago
                  Copying Kyoichiro Shigemura's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -3.10% per trade.
                  Popular Stocks
                  ---
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis